Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Martin Cannon

Concepts (288)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Dendritic Cells
26
2023
142
3.970
 Why?
Ovarian Neoplasms
23
2023
474
3.870
 Why?
Cancer Vaccines
13
2020
103
3.110
 Why?
Immunotherapy
12
2019
264
2.010
 Why?
Th17 Cells
3
2020
26
1.600
 Why?
Antigens, Neoplasm
11
2019
170
1.410
 Why?
CD4-Positive T-Lymphocytes
7
2023
181
1.120
 Why?
Uterine Cervical Neoplasms
12
2011
276
0.980
 Why?
Oncogene Proteins, Viral
7
2011
57
0.860
 Why?
Neoplasm Recurrence, Local
3
2020
645
0.810
 Why?
T-Lymphocytes, Regulatory
6
2011
85
0.780
 Why?
T-Lymphocytes, Cytotoxic
12
2013
72
0.750
 Why?
Indoleamine-Pyrrole 2,3,-Dioxygenase
3
2014
17
0.700
 Why?
Lymphocytes, Tumor-Infiltrating
4
2019
74
0.650
 Why?
CD8-Positive T-Lymphocytes
10
2023
116
0.590
 Why?
Neoplasms
4
2019
1321
0.590
 Why?
Interleukin-17
2
2020
38
0.580
 Why?
DNA-Binding Proteins
5
2007
462
0.570
 Why?
Antibodies, Monoclonal
5
2019
564
0.550
 Why?
p38 Mitogen-Activated Protein Kinases
2
2014
99
0.550
 Why?
Ascites
1
2014
28
0.480
 Why?
Immunologic Surveillance
2
2011
14
0.470
 Why?
T-Lymphocytes
5
2017
374
0.470
 Why?
Carcinoma
2
2017
154
0.420
 Why?
Signal Transduction
3
2017
1751
0.420
 Why?
Female
41
2023
28457
0.410
 Why?
Cytokines
3
2014
677
0.410
 Why?
T-Lymphocytes, Helper-Inducer
2
2011
46
0.410
 Why?
Immunotherapy, Active
1
2011
8
0.400
 Why?
Serine Endopeptidases
3
2009
57
0.400
 Why?
Cytotoxicity, Immunologic
7
2011
62
0.390
 Why?
Humans
51
2023
54304
0.360
 Why?
Immunotherapy, Adoptive
3
2005
134
0.350
 Why?
Adoptive Transfer
1
2009
38
0.350
 Why?
Interferon-gamma
7
2020
195
0.320
 Why?
Epitopes, T-Lymphocyte
3
2008
33
0.320
 Why?
Lymphocyte Activation
3
2005
197
0.290
 Why?
Adjuvants, Immunologic
3
2011
61
0.290
 Why?
Herpesvirus 4, Human
2
2005
39
0.290
 Why?
Papillomavirus Vaccines
1
2007
68
0.290
 Why?
Immunodominant Epitopes
2
2008
12
0.290
 Why?
Dependovirus
3
2011
102
0.250
 Why?
HLA-A2 Antigen
3
2009
12
0.240
 Why?
Animals
15
2023
14402
0.240
 Why?
Cell Line, Tumor
12
2017
1551
0.240
 Why?
Cell Transformation, Viral
1
2003
27
0.230
 Why?
Cell Line, Transformed
1
2003
88
0.230
 Why?
Poxviridae Infections
1
2022
4
0.220
 Why?
Poxviridae
1
2022
6
0.220
 Why?
Myxoma virus
1
2022
14
0.220
 Why?
Interferon Type I
1
2022
30
0.220
 Why?
Cystadenocarcinoma, Serous
5
2009
74
0.210
 Why?
Vaccination
4
2010
298
0.210
 Why?
Papillomavirus E7 Proteins
5
2011
33
0.210
 Why?
Receptor, erbB-2
4
2008
79
0.210
 Why?
Disease-Free Survival
2
2020
488
0.200
 Why?
Genes, MHC Class I
3
2008
13
0.200
 Why?
Injections, Intradermal
1
2020
15
0.190
 Why?
Testis
2
2011
65
0.190
 Why?
Immunity, Humoral
1
2020
25
0.190
 Why?
Coculture Techniques
3
2014
159
0.190
 Why?
Membrane Proteins
4
2011
389
0.190
 Why?
Macrophages
4
2022
404
0.190
 Why?
Folate Receptor 1
1
2020
24
0.190
 Why?
Cell Movement
2
2019
271
0.180
 Why?
Enzyme-Linked Immunosorbent Assay
2
2013
314
0.180
 Why?
Carcinoma, Lewis Lung
1
2019
11
0.180
 Why?
Self Tolerance
1
2019
1
0.170
 Why?
Costimulatory and Inhibitory T-Cell Receptors
1
2019
1
0.170
 Why?
Melanoma, Experimental
1
2019
49
0.170
 Why?
Repressor Proteins
3
2011
165
0.170
 Why?
Flow Cytometry
7
2013
547
0.170
 Why?
Transplantation, Autologous
1
2020
485
0.170
 Why?
B-Lymphocytes
4
2017
176
0.170
 Why?
Aged
11
2020
10054
0.160
 Why?
Cytotoxicity Tests, Immunologic
4
2005
31
0.160
 Why?
N-Acetylglucosaminyltransferases
1
2017
19
0.150
 Why?
Cells, Cultured
6
2014
1737
0.150
 Why?
Programmed Cell Death 1 Receptor
1
2017
40
0.150
 Why?
Receptors, Notch
1
2017
27
0.150
 Why?
HLA Antigens
4
2006
56
0.150
 Why?
Interleukin-10
1
2017
106
0.150
 Why?
Human Umbilical Vein Endothelial Cells
2
2014
95
0.150
 Why?
Mice
8
2023
6428
0.140
 Why?
Middle Aged
15
2020
13076
0.140
 Why?
Neoplastic Stem Cells
1
2017
104
0.140
 Why?
Carcinoma, Papillary
3
2005
65
0.140
 Why?
Poliovirus Vaccine, Oral
2
2005
5
0.130
 Why?
Poliovirus
2
2005
9
0.130
 Why?
Genetic Vectors
3
2011
139
0.130
 Why?
Clinical Trials, Phase I as Topic
1
2015
30
0.130
 Why?
Antigen Presentation
5
2009
28
0.130
 Why?
Neoplasm Proteins
1
2017
360
0.130
 Why?
Galectin 3
1
2014
15
0.130
 Why?
Kallikreins
2
2005
22
0.130
 Why?
Adenocarcinoma
3
2004
428
0.130
 Why?
Adult
14
2011
14189
0.120
 Why?
Neoplasm Invasiveness
3
2017
294
0.120
 Why?
Cystadenocarcinoma, Papillary
2
2005
15
0.120
 Why?
Histocompatibility Antigens Class I
2
2005
52
0.120
 Why?
Peptide Fragments
4
2009
242
0.120
 Why?
Endometrial Neoplasms
2
2005
145
0.120
 Why?
Papillomavirus Infections
3
2011
163
0.120
 Why?
Uterine Neoplasms
2
2005
65
0.120
 Why?
Intracellular Signaling Peptides and Proteins
2
2022
151
0.110
 Why?
Mice, Inbred C57BL
3
2017
2002
0.110
 Why?
Mutation
1
2019
1504
0.100
 Why?
Lymphocytes
1
2013
168
0.100
 Why?
V-Set Domain-Containing T-Cell Activation Inhibitor 1
1
2011
4
0.100
 Why?
Antigens, Viral
3
2007
58
0.100
 Why?
rho GTP-Binding Proteins
1
2011
6
0.100
 Why?
Clonal Anergy
1
2011
14
0.100
 Why?
Drug Resistance, Neoplasm
5
2017
309
0.100
 Why?
A Kinase Anchor Proteins
1
2011
1
0.100
 Why?
Calmodulin-Binding Proteins
1
2011
9
0.100
 Why?
Antigen-Presenting Cells
1
2011
25
0.100
 Why?
Antigens, Surface
1
2011
55
0.100
 Why?
Human papillomavirus 16
1
2011
48
0.100
 Why?
Antineoplastic Agents, Alkylating
1
2011
74
0.100
 Why?
Uterine Cervical Dysplasia
1
2011
51
0.100
 Why?
Immunity, Cellular
2
2008
80
0.100
 Why?
Cyclophosphamide
1
2011
172
0.100
 Why?
Diphosphonates
1
2011
96
0.090
 Why?
Prostate
1
2011
123
0.090
 Why?
Imidazoles
1
2011
143
0.090
 Why?
Papillomaviridae
3
2005
107
0.090
 Why?
Killer Cells, Natural
3
2005
106
0.090
 Why?
Phenotype
1
2013
820
0.090
 Why?
Gene Expression Regulation, Neoplastic
4
2011
868
0.090
 Why?
Neoplasm Staging
3
2007
805
0.090
 Why?
Tumor Microenvironment
2
2023
210
0.090
 Why?
K562 Cells
2
2008
47
0.090
 Why?
Gene Expression Profiling
2
2005
1141
0.090
 Why?
Carrier Proteins
1
2011
360
0.080
 Why?
CA-125 Antigen
1
2008
20
0.080
 Why?
Immediate-Early Proteins
1
2008
19
0.080
 Why?
Cytomegalovirus
1
2008
30
0.080
 Why?
Green Fluorescent Proteins
1
2008
110
0.080
 Why?
Interleukin-4
2
2005
48
0.080
 Why?
RNA, Messenger
4
2005
1203
0.080
 Why?
Antibody Formation
1
2007
69
0.080
 Why?
Antibodies, Viral
1
2007
124
0.080
 Why?
RNA Interference
2
2017
195
0.070
 Why?
Prostatic Neoplasms
1
2011
421
0.070
 Why?
Ovary
3
2017
105
0.070
 Why?
Amino Acid Sequence
2
2005
766
0.070
 Why?
Molecular Sequence Data
2
2005
980
0.070
 Why?
Oligonucleotide Array Sequence Analysis
2
2005
474
0.070
 Why?
Hypersensitivity, Delayed
1
2005
21
0.070
 Why?
Recombinant Proteins
1
2007
570
0.070
 Why?
Neoplasms, Squamous Cell
1
2005
9
0.070
 Why?
Electroporation
1
2005
17
0.070
 Why?
Enterotoxins
1
2005
12
0.070
 Why?
Monocytes
2
2022
156
0.070
 Why?
Gene Transfer Techniques
1
2005
41
0.070
 Why?
Genes, erbB-2
1
2005
8
0.070
 Why?
Poliomyelitis
1
2005
15
0.070
 Why?
Breast Neoplasms
3
2003
1248
0.070
 Why?
Interleukin-12
1
2005
37
0.070
 Why?
Antigens, Heterophile
1
2005
2
0.070
 Why?
Immunologic Memory
1
2005
32
0.070
 Why?
Plasmodium falciparum
1
2005
18
0.070
 Why?
Malaria, Falciparum
1
2005
12
0.060
 Why?
Cell Line
4
2010
1152
0.060
 Why?
Burkitt Lymphoma
1
2005
29
0.060
 Why?
Endemic Diseases
1
2005
29
0.060
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2008
674
0.060
 Why?
Epstein-Barr Virus Infections
1
2005
35
0.060
 Why?
Gangliosides
1
2004
9
0.060
 Why?
Ascitic Fluid
1
2004
13
0.060
 Why?
Genetic Therapy
1
2005
121
0.060
 Why?
Vaccines, Subunit
1
2004
20
0.060
 Why?
Ovariectomy
1
2004
127
0.060
 Why?
Hysterectomy
1
2004
89
0.060
 Why?
Immunization, Passive
1
2004
35
0.060
 Why?
Proteins
2
2005
376
0.060
 Why?
Interleukin-6
1
2005
315
0.060
 Why?
Clinical Trials as Topic
2
2007
490
0.060
 Why?
Tumor Necrosis Factor-alpha
2
2019
435
0.060
 Why?
Cell Differentiation
2
2004
720
0.060
 Why?
Virus Latency
1
2003
46
0.060
 Why?
Epithelial Cells
1
2005
255
0.060
 Why?
Protein Binding
1
2005
736
0.060
 Why?
Vaccinia virus
1
2022
7
0.060
 Why?
Host Specificity
1
2022
5
0.060
 Why?
Cell Adhesion Molecules
1
2003
87
0.060
 Why?
Cell Communication
1
2003
72
0.050
 Why?
Nucleotidyltransferases
1
2022
15
0.050
 Why?
Mammals
1
2022
59
0.050
 Why?
Tumor Cells, Cultured
4
2003
477
0.050
 Why?
Xenograft Model Antitumor Assays
2
2017
219
0.050
 Why?
Disease Progression
2
2019
915
0.050
 Why?
Rabbits
1
2022
425
0.050
 Why?
Down-Regulation
1
2003
388
0.050
 Why?
Viral Proteins
1
2022
158
0.050
 Why?
Immunohistochemistry
4
2005
1090
0.050
 Why?
Carcinoma, Squamous Cell
1
2004
385
0.050
 Why?
Transcriptome
1
2022
346
0.050
 Why?
Endothelium
1
2019
45
0.040
 Why?
Intercellular Adhesion Molecule-1
1
2019
75
0.040
 Why?
Gene Expression
3
2008
664
0.040
 Why?
Injections, Intraperitoneal
2
2010
59
0.040
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2004
1060
0.040
 Why?
Tissue Banks
1
2017
8
0.040
 Why?
Mice, Inbred NOD
1
2017
99
0.040
 Why?
STAT3 Transcription Factor
1
2017
88
0.040
 Why?
Glycosylation
1
2017
112
0.040
 Why?
Antibodies, Monoclonal, Humanized
3
2004
240
0.040
 Why?
Tumor Burden
1
2017
141
0.040
 Why?
RNA, Small Interfering
1
2017
253
0.040
 Why?
Multiple Myeloma
1
2011
3049
0.040
 Why?
Protein Processing, Post-Translational
1
2017
183
0.030
 Why?
Lung Neoplasms
1
2002
643
0.030
 Why?
Kaplan-Meier Estimate
1
2017
514
0.030
 Why?
Survival Analysis
2
2010
736
0.030
 Why?
Apoptosis
2
2014
1302
0.030
 Why?
Neovascularization, Pathologic
1
2014
168
0.030
 Why?
Anti-Bacterial Agents
1
2019
825
0.030
 Why?
Interleukin-2
2
2003
75
0.030
 Why?
Vaginal Smears
1
2011
31
0.030
 Why?
Organ Specificity
1
2011
126
0.020
 Why?
Prostate-Specific Antigen
1
2011
57
0.020
 Why?
DNA, Viral
1
2011
143
0.020
 Why?
Major Histocompatibility Complex
1
2010
14
0.020
 Why?
Prognosis
2
2005
2126
0.020
 Why?
Transduction, Genetic
1
2008
50
0.020
 Why?
Fluorescent Antibody Technique
1
2008
141
0.020
 Why?
Leukocytes, Mononuclear
1
2008
133
0.020
 Why?
T-Lymphocyte Subsets
1
2007
41
0.020
 Why?
Alphapapillomavirus
1
2007
16
0.020
 Why?
Models, Immunological
1
2007
10
0.020
 Why?
Immune Tolerance
1
2007
105
0.020
 Why?
Aged, 80 and over
2
2005
3430
0.020
 Why?
HLA-B Antigens
1
2006
7
0.020
 Why?
Clone Cells
1
2006
89
0.020
 Why?
Adolescent
2
2011
6896
0.020
 Why?
Immunity, Innate
1
2007
114
0.020
 Why?
Claudin-3
1
2005
5
0.020
 Why?
Claudin-4
1
2005
7
0.020
 Why?
Pore Forming Cytotoxic Proteins
1
2005
6
0.020
 Why?
Perforin
1
2005
8
0.020
 Why?
Mice, Inbred C3H
1
2005
82
0.020
 Why?
Combined Modality Therapy
1
2007
693
0.020
 Why?
Male
3
2011
27335
0.020
 Why?
Protein Sorting Signals
1
2005
10
0.020
 Why?
Protein Engineering
1
2005
21
0.020
 Why?
Mice, SCID
1
2005
196
0.020
 Why?
Histocompatibility Antigens Class II
1
2005
44
0.020
 Why?
Protein Folding
1
2005
52
0.020
 Why?
Plasmids
1
2005
180
0.020
 Why?
Species Specificity
1
2005
206
0.020
 Why?
Peptides
1
2006
276
0.020
 Why?
Epithelium
1
2004
68
0.020
 Why?
Endocytosis
1
2005
60
0.020
 Why?
Radiotherapy, Adjuvant
1
2004
66
0.020
 Why?
Carboplatin
1
2004
63
0.020
 Why?
Receptors, Cell Surface
1
2005
130
0.020
 Why?
Antineoplastic Agents, Hormonal
1
2004
49
0.020
 Why?
Disease Models, Animal
1
2010
1651
0.020
 Why?
Transfection
1
2005
399
0.010
 Why?
Antibody-Dependent Cell Cytotoxicity
1
2003
15
0.010
 Why?
Paclitaxel
1
2004
103
0.010
 Why?
Tumor Stem Cell Assay
1
2003
21
0.010
 Why?
Polymerase Chain Reaction
1
2005
531
0.010
 Why?
Proportional Hazards Models
1
2005
430
0.010
 Why?
Membrane Glycoproteins
1
2005
270
0.010
 Why?
Cervix Uteri
1
2004
53
0.010
 Why?
Swine
1
2005
429
0.010
 Why?
Keratinocytes
1
2004
96
0.010
 Why?
Up-Regulation
1
2005
509
0.010
 Why?
Kinetics
1
2005
692
0.010
 Why?
Receptors, Antigen, T-Cell
1
2003
50
0.010
 Why?
Time Factors
1
2010
3207
0.010
 Why?
Leukocytes
1
2003
86
0.010
 Why?
Cell Culture Techniques
1
2003
112
0.010
 Why?
Doxorubicin
1
2004
259
0.010
 Why?
Cell Death
1
2003
223
0.010
 Why?
Tumor Virus Infections
1
2002
43
0.010
 Why?
Survival Rate
1
2005
954
0.010
 Why?
Antibodies, Monoclonal, Murine-Derived
1
2002
55
0.010
 Why?
Cisplatin
1
2004
351
0.010
 Why?
Fatal Outcome
1
2002
225
0.010
 Why?
Young Adult
1
2011
4313
0.010
 Why?
Cell Division
1
2002
330
0.010
 Why?
Case-Control Studies
1
2004
1229
0.010
 Why?
Prospective Studies
1
2004
2604
0.010
 Why?
Risk Factors
1
2004
3934
0.010
 Why?
Antineoplastic Agents
1
2002
1300
0.010
 Why?
Cannon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (288) concept(s)
_
Co-Authors Expand Description
See all (19) people
_
Similar People Expand Description
See all (32) people
_
Same Department Expand Description
Search Department